Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
![Foto de Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)](/img/noimage.png)
![Foto de VU University Amsterdam](/img/noimage_org.png)
VU University Amsterdam
Ámsterdam, HolandaPublicacións en colaboración con investigadores/as de VU University Amsterdam (12)
2023
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
2021
-
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 12, pp. 4105-4106
2020
-
Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis
Translational Psychiatry, Vol. 10, Núm. 1
2019
-
Cellular Senescence: Defining a Path Forward
Cell, Vol. 179, Núm. 4, pp. 813-827
2014
-
Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations
Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736
-
The application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to support drug discovery research
PLoS ONE, Vol. 9, Núm. 12
2010
-
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action
Cell Metabolism, Vol. 12, Núm. 3, pp. 237-249